DK0984957T3 - Hidtil ukendt form af S-omeprazol - Google Patents

Hidtil ukendt form af S-omeprazol

Info

Publication number
DK0984957T3
DK0984957T3 DK98926005T DK98926005T DK0984957T3 DK 0984957 T3 DK0984957 T3 DK 0984957T3 DK 98926005 T DK98926005 T DK 98926005T DK 98926005 T DK98926005 T DK 98926005T DK 0984957 T3 DK0984957 T3 DK 0984957T3
Authority
DK
Denmark
Prior art keywords
omeprazole
hitherto unknown
unknown form
hitherto
unknown
Prior art date
Application number
DK98926005T
Other languages
Danish (da)
English (en)
Inventor
Hanna Cotton
Anders Kronstroem
Anders Mattson
Eva Moeller
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=20407186&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0984957(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Application granted granted Critical
Publication of DK0984957T3 publication Critical patent/DK0984957T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Glass Compositions (AREA)
DK98926005T 1997-05-30 1998-05-25 Hidtil ukendt form af S-omeprazol DK0984957T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9702065A SE510650C2 (sv) 1997-05-30 1997-05-30 Ny förening
PCT/SE1998/000974 WO1998054171A1 (fr) 1997-05-30 1998-05-25 Nouvelle forme de s-omeprazole

Publications (1)

Publication Number Publication Date
DK0984957T3 true DK0984957T3 (da) 2003-06-30

Family

ID=20407186

Family Applications (2)

Application Number Title Priority Date Filing Date
DK98926005T DK0984957T3 (da) 1997-05-30 1998-05-25 Hidtil ukendt form af S-omeprazol
DK02019642T DK1273581T3 (da) 1997-05-30 1998-05-25 Ny fremgangsmåde til fremstilling af trihydratet af magnesiumsaltet af S-omeprazol

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK02019642T DK1273581T3 (da) 1997-05-30 1998-05-25 Ny fremgangsmåde til fremstilling af trihydratet af magnesiumsaltet af S-omeprazol

Country Status (43)

Country Link
US (6) US6369085B1 (fr)
EP (2) EP0984957B3 (fr)
JP (2) JP4002303B2 (fr)
KR (2) KR100527804B1 (fr)
CN (1) CN1161351C (fr)
AR (2) AR012717A1 (fr)
AT (2) ATE291574T1 (fr)
AU (1) AU722839B2 (fr)
BR (1) BR9809509A (fr)
CA (2) CA2290963C (fr)
CY (1) CY2012029I2 (fr)
CZ (1) CZ297585B6 (fr)
DE (3) DE69814069T3 (fr)
DK (2) DK0984957T3 (fr)
DZ (1) DZ2495A1 (fr)
EE (1) EE03875B1 (fr)
EG (1) EG24291A (fr)
ES (2) ES2195345T7 (fr)
HR (1) HRP980263B1 (fr)
HU (1) HU225987B1 (fr)
ID (1) ID29306A (fr)
IL (1) IL132947A0 (fr)
IS (2) IS2142B (fr)
LU (2) LU91871I2 (fr)
MA (1) MA26500A1 (fr)
ME (3) MEP18008A (fr)
MY (2) MY127793A (fr)
NO (3) NO317518B1 (fr)
NZ (1) NZ500991A (fr)
PL (1) PL193546B1 (fr)
PT (2) PT1273581E (fr)
RS (2) RS50067B (fr)
RU (1) RU2184115C2 (fr)
SA (2) SA05260296B1 (fr)
SE (1) SE510650C2 (fr)
SI (2) SI1273581T1 (fr)
SK (2) SK284837B6 (fr)
TN (1) TNSN98074A1 (fr)
TR (1) TR199902934T2 (fr)
TW (1) TW538040B (fr)
UA (1) UA60334C2 (fr)
WO (1) WO1998054171A1 (fr)
ZA (1) ZA984179B (fr)

Families Citing this family (114)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6875872B1 (en) * 1993-05-28 2005-04-05 Astrazeneca Compounds
SE9301830D0 (sv) * 1993-05-28 1993-05-28 Ab Astra New compounds
GB2324093A (en) 1996-01-04 1998-10-14 Rican Limited Helicobacter pylori bacterioferritin
US5840737A (en) 1996-01-04 1998-11-24 The Curators Of The University Of Missouri Omeprazole solution and method for using same
US6645988B2 (en) * 1996-01-04 2003-11-11 Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
US6699885B2 (en) * 1996-01-04 2004-03-02 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and methods of using same
US6489346B1 (en) * 1996-01-04 2002-12-03 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
SE510650C2 (sv) 1997-05-30 1999-06-14 Astra Ab Ny förening
SE9900274D0 (sv) * 1999-01-28 1999-01-28 Astra Ab New compound
US6369087B1 (en) * 1999-08-26 2002-04-09 Robert R. Whittle Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same
US6316020B1 (en) 1999-08-26 2001-11-13 Robert R. Whittle Pharmaceutical formulations
US8206741B2 (en) 2001-06-01 2012-06-26 Pozen Inc. Pharmaceutical compositions for the coordinated delivery of NSAIDs
ES2286408T3 (es) 2002-03-05 2007-12-01 Astrazeneca Ab Sales de alquilamonio de omeprazol e esomeprazol.
WO2003089408A2 (fr) * 2002-04-22 2003-10-30 Sun Pharmaceutical Industries Limited Pyridinylmethyl-sulphinyl-benzimidazole substitue optiquement actif et sels
US7169793B2 (en) 2002-06-27 2007-01-30 Dr. Reddy's Laboratories Limited Process for preparation of optically pure or optically enriched sulfoxide compounds, including amorphous esomeprazole and salts thereof
ATE353887T1 (de) * 2002-06-27 2007-03-15 Reddys Lab Ltd Dr Verfahren zur herstellung optisch reiner oder optisch angereicherter sulfoxidverbindungen einschliesslich amorphen esomeprazols und dessen salze
TW200410955A (en) 2002-07-29 2004-07-01 Altana Pharma Ag Novel salt of (S)-PANTOPRAZOLE
EP1546131A1 (fr) * 2002-08-30 2005-06-29 Dr. Reddy's Laboratories Ltd. Hydrates amorphes d'esomeprazole magnesium et leur procede de preparation
WO2004035052A1 (fr) * 2002-10-16 2004-04-29 Takeda Pharmaceutical Company Limited Preparations solides stables
EA200500673A1 (ru) * 2002-10-22 2005-12-29 Рэнбакси Лабораториз Лимитед Аморфная форма соли эзомепразола, способ ее получения и фармацевтическая композиция на её основе
US20040242642A1 (en) * 2002-11-18 2004-12-02 Dr. Reddy's Laboratories Limited Crystalline esomeprazole compounds and process for the preparation thereof
US20060094762A1 (en) * 2003-01-07 2006-05-04 Yatendra Kumar Magnesium salt of imidazole derivative
WO2004089935A1 (fr) * 2003-04-10 2004-10-21 Hetero Drugs Limitd Nouvelles formes cristallines de s-omeprazole magnesium
CN1842525A (zh) 2003-05-05 2006-10-04 兰贝克赛实验室有限公司 苯并咪唑衍生物的钡盐
US8993599B2 (en) 2003-07-18 2015-03-31 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US20060189590A1 (en) * 2003-07-23 2006-08-24 Bernhard Kohl Alkaline salts of proton pump inhibitors
CN100457104C (zh) * 2003-07-23 2009-02-04 尼科梅德有限责任公司 质子泵抑制剂的碱性盐
SE0302382D0 (sv) 2003-09-04 2003-09-04 Astrazeneca Ab New salts II
SE0302381D0 (sv) 2003-09-04 2003-09-04 Astrazeneca Ab New salts I
US20050075371A1 (en) * 2003-10-03 2005-04-07 Allergan, Inc. Methods and compositions for the oral administration of prodrugs of proton pump inhibitors
US20070292498A1 (en) * 2003-11-05 2007-12-20 Warren Hall Combinations of proton pump inhibitors, sleep aids, buffers and pain relievers
JP2007523163A (ja) * 2004-02-18 2007-08-16 アラーガン、インコーポレイテッド プロトンポンプインヒビターのプロドラッグの投与のための方法および組成物
AU2005216863A1 (en) * 2004-02-18 2005-09-09 Allergan, Inc. Methods and compositions for the intravenous administration of compounds related to proton pump inhibitors
EP1742630A4 (fr) * 2004-04-16 2010-01-20 Santarus Inc Combinaison d'un inhibiteur de la pompe a protons, d'un agent tampon et d'un agent prokinetique
US8906940B2 (en) 2004-05-25 2014-12-09 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US20050267157A1 (en) * 2004-05-28 2005-12-01 David White Magnesium-S-omeprazole
US20050267159A1 (en) * 2004-05-28 2005-12-01 Aaipharma, Inc. Magnesium complexes of S-omeprazole
US8461187B2 (en) 2004-06-16 2013-06-11 Takeda Pharmaceuticals U.S.A., Inc. Multiple PPI dosage form
WO2006001753A1 (fr) * 2004-06-24 2006-01-05 Astrazeneca Ab Nouveau procede de preparation de modifications de cristal a utiliser dans la preparation de sel de sodium d'esomeprazole
ES2246149B1 (es) 2004-07-02 2007-06-01 Esteve Quimica, S.A. Formas solidas de la sal magnesica de s-omeprazol y procedimientos para su preparacion.
US20060024362A1 (en) * 2004-07-29 2006-02-02 Pawan Seth Composition comprising a benzimidazole and process for its manufacture
US20060160783A1 (en) * 2004-12-30 2006-07-20 Transform Pharmaceuticals, Inc. Novel omeprazole forms and related methods
ES2259269B1 (es) 2005-03-03 2007-11-01 Esteve Quimica, S.A. Procedimiento para la preparacion de derivados de 2-(2-piridilmetilsulfinil)-bencimidazol opticamente activos.
US20060210637A1 (en) * 2005-03-17 2006-09-21 Qpharma, Llc Stable tablet dosage forms of proton pump inhibitors
RU2007145207A (ru) * 2005-05-06 2009-06-20 Гленмарк Фармасьютикалз Лимитед (In) Стронциваемая соль эзомепразола, способ ее получения и содержащее ее фармацевтические композиции
US7563812B2 (en) 2005-06-15 2009-07-21 Hetero Drugs Limited Amorphous esomeprazole hydrate
WO2007008588A2 (fr) * 2005-07-07 2007-01-18 Dr. Reddy's Laboratories Ltd. Omeprazole de forme b
KR100641534B1 (ko) 2005-07-28 2006-11-01 한미약품 주식회사 에스오메프라졸 및 그의 염의 제조방법
US20070026071A1 (en) * 2005-07-28 2007-02-01 Qpharma, Llc Magnesium salt proton pump inhibitor dosage forms
WO2007031845A2 (fr) * 2005-09-14 2007-03-22 Glenmark Pharmaceuticals Limited Formes polymorphiques de sels de magnesium de (s)-omeprazole et procedes de preparation desdites formes
EP1934201A1 (fr) * 2005-10-06 2008-06-25 Auspex Pharmaceuticals Inc. Inhibiteurs deutériés d'atpase h+,k+ gastrique ayant des propriétés thérapeutiques renforcées
WO2007049914A1 (fr) * 2005-10-26 2007-05-03 Hanmi Pharm. Co., Ltd. S-omeprazole strontium ou hydrate de ce composé, méthode de synthèse et préparation pharmaceutique le comprenant
US7576219B2 (en) * 2005-10-26 2009-08-18 Hanmi Pharm. Co., Ltd Crystalline S-omeprazole strontium hydrate, method for preparing same, and pharmaceutical composition containing same
EP1801110A1 (fr) 2005-12-22 2007-06-27 KRKA, tovarna zdravil, d.d., Novo mesto Sel d'arginine d'ésoméprazole
US7553857B2 (en) * 2005-12-23 2009-06-30 Lek Pharmaceuticals D.D. S-omeprazole magnesium
CN100384839C (zh) * 2006-02-17 2008-04-30 中国科学院上海有机化学研究所 [(取代的吡啶基)甲基]亚磺酰基-1h-苯并咪唑类化合物及其对映体的锌盐的制备方法
US7579476B2 (en) * 2006-02-24 2009-08-25 Praktikatalyst Pharma, Llc Transition metal mediated oxidation of hetero atoms in organic molecules coordinated to transition metals
US8063074B2 (en) 2006-05-04 2011-11-22 Dr. Reddy's Laboratories Limited Polymorphic forms of esomeprazole sodium
WO2007148213A2 (fr) * 2006-06-21 2007-12-27 Glenmark Pharmaceuticals Limited Nouveau polymorphe de potassium d'ésoméprazole
EP2068841B1 (fr) 2006-10-05 2018-09-26 Santarus, Inc. Nouvelles formulations pour une libération immédiate d'inhibiteurs de pompe à protons et procédés d'utilisation de ces formulations
CA2667682A1 (fr) 2006-10-27 2008-05-15 The Curators Of The University Of Missouri Compositions comprenant des agents d'inhibition de la pompe a protons labiles d'acide, au moins un autre agent pharmaceutiquement actif et leurs procedes d'utilisation
EP1947099A1 (fr) * 2007-01-18 2008-07-23 LEK Pharmaceuticals D.D. Procédé pour l'élimination de solvant des sels d'oméprazole
EP2114919A2 (fr) 2007-01-31 2009-11-11 Krka Tovarna Zdravil, D.D., Novo Mesto Procédé de préparation d'oméprazole optiquement pur
JP2010519284A (ja) * 2007-02-21 2010-06-03 シプラ・リミテッド エソメプラゾールマグネシウム二水和物の調製方法
KR101303813B1 (ko) * 2007-04-16 2013-09-04 에스케이케미칼주식회사 라세믹 오메프라졸로부터 에스오메프라졸의 개선된제조방법
EP2000468A1 (fr) 2007-05-09 2008-12-10 Dr. Reddy's Laboratories Ltd. Sels d'ésoméprazole et procédés pour leur préparation
US8492551B2 (en) * 2007-06-07 2013-07-23 Aurobindo Pharma. Ltd. Process for preparing an optically active proton pump inhibitor
FR2920428B1 (fr) * 2007-08-29 2012-06-15 Univ Rouen Procede de dedoublement de sels de l'omeprazole
EP2195309A4 (fr) * 2007-10-08 2013-04-24 Hetero Drugs Ltd Polymorphes de sels de l'ésoméprazole
WO2009049160A1 (fr) 2007-10-12 2009-04-16 Takeda Pharmaceuticals North America Procédés de traitement de troubles gastro-intestinaux indépendants de la prise alimentaire
WO2009074997A2 (fr) * 2007-12-10 2009-06-18 Lee Pharma Ltd. Nouveau procédé de préparation de sel de magnésium cristallin de (s)-oméprazole dihydraté
WO2009099933A2 (fr) * 2008-02-01 2009-08-13 Dr. Reddy's Laboratories Ltd. Préparation de magnésium d’ésoméprazole et de ses hydrates
WO2009137648A1 (fr) * 2008-05-09 2009-11-12 Aptapharma, Inc. Pastilles multicouches inhibant la pompe à protons
US20090280173A1 (en) * 2008-05-09 2009-11-12 Ishwar Chauhan Multilayer Omeprazole Tablets
EP2143722A1 (fr) 2008-07-09 2010-01-13 Lek Pharmaceuticals D.D. Procédé de préparation de sodium ésoméprazole de haute pureté chimique et nouvelles formes de sodium ésoméprazole
EP2147918A1 (fr) * 2008-07-21 2010-01-27 LEK Pharmaceuticals D.D. Procédé de préparation de magnésium d'oméprazole S dans une forme stable
US9220698B2 (en) 2008-09-09 2015-12-29 Pozen Inc. Method for delivering a pharmaceutical composition to patient in need thereof
CN101391993B (zh) * 2008-10-28 2012-07-04 安徽美诺华药物化学有限公司 通过与(s)-(-)-1,1'-联萘-2,2'-二酚形成包合配合物制备s-奥美拉唑及其盐的方法
WO2010097583A1 (fr) 2009-02-24 2010-09-02 Cipla Limited Polymorphe de l'ésoméprazole de potassium et sa préparation
US20100267959A1 (en) * 2009-04-15 2010-10-21 Glenmark Generics Limited Process for the preparation of esomeprazole magnesium dihydrate
WO2010122583A2 (fr) 2009-04-24 2010-10-28 Rubicon Research Private Limited Compositions pharmaceutiques orales comprenant des substances labiles en milieu acide
WO2010150276A2 (fr) * 2009-06-02 2010-12-29 Sun Pharmaceutical Industries Limited Procédé d'élaboration de composés sulfoxyde
EP2445344A4 (fr) * 2009-06-25 2013-01-23 Pozen Inc Procédé de traitement d'un patient nécessitant une thérapie à l'aspirine
KR20120030106A (ko) 2009-06-25 2012-03-27 아스트라제네카 아베 Ｎｓａｉｄ-연관된 궤양의 발생 위험이 있는 환자의 치료 방법
WO2011012957A1 (fr) * 2009-07-29 2011-02-03 Orchid Chemicals & Pharmaceuticals Ltd Procédé perfectionné pour la préparation d'ésoméprazole magnésique dihydraté
WO2011058569A1 (fr) 2009-11-12 2011-05-19 Hetero Research Foundation Procédé de dédoublement de l'oméprazole
CN102884178B (zh) 2009-12-08 2014-12-03 科德克希思公司 拉唑化合物的合成
US20110207779A1 (en) * 2010-02-25 2011-08-25 Glenmark Generics Ltd Process for the preparation of esomeprazole magnesium
FR2959509B1 (fr) 2010-05-03 2012-07-13 Prod Chim Auxiliaires Et De Synthese Phase precurseur et son utilisation pour preparer le sel de magnesium tetrahydrate d'un enantiomere d'omeprazole
CN102241668B (zh) * 2010-05-11 2015-11-25 中国科学院成都有机化学有限公司 S-奥美拉唑盐
EP2649187B1 (fr) 2010-12-08 2017-11-22 Codexis, Inc. Biocatalyseurs et procédés de synthèse de l'armodafinil
CN102757421A (zh) * 2011-04-29 2012-10-31 江苏正大天晴药业股份有限公司 埃索美拉唑的纯化方法
CN104844577A (zh) * 2011-07-31 2015-08-19 连云港润众制药有限公司 埃索美拉唑镁的晶型
CN102924435B (zh) * 2011-11-25 2014-06-25 成都自豪药业有限公司 S-奥美拉唑镁盐的晶型及其制备方法
WO2013088272A1 (fr) * 2011-12-14 2013-06-20 Wockhardt Limited Composition pharmaceutique comprenant du dihydrate de magnésium d'ésoméprazole
EP2797600A4 (fr) 2011-12-28 2015-09-16 Pozen Inc Compositions et procédés d'administration d'oméprazole plus acide acétylsalicylique améliorés
CN102584792B (zh) * 2012-01-06 2014-06-11 南京优科生物医药研究有限公司 制备高纯度的埃索美拉唑盐的方法
CN102993184A (zh) * 2013-01-08 2013-03-27 湖南方盛制药股份有限公司 一种埃索美拉唑及其镁盐三水合物的制备方法
CN104250243B (zh) * 2013-06-27 2016-12-28 四川国为制药有限公司 一种埃索美拉唑镁二水合物a晶型的制备方法
CN103570686B (zh) * 2013-10-14 2015-04-01 哈药集团技术中心 一种埃索美拉唑钠的合成及精制工艺
CN104725357A (zh) * 2013-12-24 2015-06-24 苏州联友制药技术有限公司 一种埃索美拉唑镁二水合物晶型b的制备方法
FR3018812A1 (fr) 2014-03-21 2015-09-25 Minakem Nouvelle phase intermediaire de la forme a du sel de magnesium dihydrate d'un enantiomere de l'omeprazole
CN104447699A (zh) * 2014-12-10 2015-03-25 哈药集团技术中心 一种埃索美拉唑镁三水合物的制备方法
CN105111188B (zh) * 2015-08-19 2018-01-19 扬子江药业集团有限公司 一种埃索美拉唑镁三水合物晶型的制备方法
WO2017145146A1 (fr) 2016-02-25 2017-08-31 Dexcel Pharma Technologies Ltd. Compositions comprenant des inhibiteurs de la pompe à protons
CN106397402B (zh) * 2016-08-30 2019-05-03 山东罗欣药业集团股份有限公司 一种埃索美拉唑镁晶型化合物及其制备方法
KR102080023B1 (ko) 2018-01-29 2020-02-21 주식회사 종근당 에스오메프라졸 및 탄산수소나트륨을 포함하는 안정한 약제학적 조성물
KR102006777B1 (ko) 2018-01-29 2019-10-08 주식회사 종근당 에스오메프라졸 및 탄산수소나트륨을 포함하는 약제학적 제제
US20210313015A1 (en) * 2018-08-21 2021-10-07 Towa Pharmaceutical Co., Ltd. Specifically-shaped crystal of compound and method for producing same
US12251375B2 (en) 2018-08-23 2025-03-18 Chong Kun Dang Pharmaceutical Corp. Pharmaceutical preparation having excellent dissolution properties, containing esomeprazole and sodium bicarbonate
KR102432084B1 (ko) 2021-11-16 2022-08-12 알리코제약(주) S-오메프라졸을 함유하는 안정성이 개선되고 소형화된 정제
JP2025532389A (ja) 2022-10-04 2025-09-29 ザビリュク，アルセニー 大動脈弁の石灰化の抑制
CN119320381B (zh) * 2024-10-14 2025-12-12 山东益康药业股份有限公司 奥美拉唑与3,5-二硝基苯甲酸的共晶物及其用途
CN119320380B (zh) * 2024-10-14 2025-11-25 山东益康药业股份有限公司 奥美拉唑与2,6-二羟基苯甲酸的共晶物及其用途

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE7804231L (sv) 1978-04-14 1979-10-15 Haessle Ab Magsyrasekretionsmedel
SE8301182D0 (sv) 1983-03-04 1983-03-04 Haessle Ab Novel compounds
US5244891A (en) 1985-08-05 1993-09-14 Bristol-Myers Squibb Company Injectable compositions of cefepime dihydrochloride hydrate
GB2189698A (en) 1986-04-30 1987-11-04 Haessle Ab Coated omeprazole tablets
US5204118A (en) 1989-11-02 1993-04-20 Mcneil-Ppc, Inc. Pharmaceutical compositions and methods for treating the symptoms of overindulgence
SE9002043D0 (sv) * 1990-06-07 1990-06-07 Astra Ab Improved method for synthesis
DE4035455A1 (de) * 1990-11-08 1992-05-14 Byk Gulden Lomberg Chem Fab Enantiomerentrennung
US5360582A (en) 1991-07-15 1994-11-01 Minnesota Mining And Manufacturing Company Nonlinear optical materials containing polar disulfone-functionalized molecules
SE9301830D0 (sv) * 1993-05-28 1993-05-28 Ab Astra New compounds
US5877192A (en) 1993-05-28 1999-03-02 Astra Aktiebolag Method for the treatment of gastric acid-related diseases and production of medication using (-) enantiomer of omeprazole
SE9302396D0 (sv) * 1993-07-09 1993-07-09 Ab Astra A novel compound form
SE9302395D0 (sv) * 1993-07-09 1993-07-09 Ab Astra New pharmaceutical formulation
FR2719045B1 (fr) * 1994-04-20 1996-05-31 Rhone Poulenc Chimie Procédé de préparation d'acide L-aspartique à partir d'aspartate d'ammonium.
DK0723436T3 (da) 1994-07-08 2001-11-26 Astrazeneca Ab Tabletteret flerenhedsdoseringsform
FR2722191B1 (fr) 1994-07-08 1996-08-23 Rhone Poulenc Rorer Sa Procede de preparation du trihydrate du (2r,3s)-3-tertbutoxycarbonylamino-2-hydroxy-3-phenylpropionate de 4-acetoxy2alpha-benzoyloxy-5beta,20epoxy-1,7beta,10beta trihydroxy-9-oxo-tax-11-en-13alpha-yle
SE504459C2 (sv) 1994-07-15 1997-02-17 Astra Ab Förfarande för framställning av substituerade sulfoxider
CN1067998C (zh) 1994-11-14 2001-07-04 第一制药株式会社 药用水合物
GB9423970D0 (en) 1994-11-28 1995-01-11 Astra Ab Oxidation
SE9500422D0 (sv) 1995-02-06 1995-02-06 Astra Ab New oral pharmaceutical dosage forms
CN1042423C (zh) 1995-05-25 1999-03-10 常州市第四制药厂 奥美拉唑盐水合物及其制备方法
SE9600070D0 (sv) 1996-01-08 1996-01-08 Astra Ab New oral pharmaceutical dosage forms
SE9600071D0 (sv) 1996-01-08 1996-01-08 Astra Ab New oral formulation of two active ingredients I
SE9600072D0 (sv) 1996-01-08 1996-01-08 Astra Ab New oral formulation of two active ingredients II
SE510650C2 (sv) * 1997-05-30 1999-06-14 Astra Ab Ny förening
US6747155B2 (en) 1997-05-30 2004-06-08 Astrazeneca Ab Process
AR057181A1 (es) 2005-11-30 2007-11-21 Astra Ab Nueva forma de dosificacion de combinacion

Also Published As

Publication number Publication date
US8466175B2 (en) 2013-06-18
SK284837B6 (sk) 2005-12-01
KR20050042827A (ko) 2005-05-10
CY2012029I1 (el) 2015-08-05
SA98190280B1 (ar) 2006-07-04
SK162599A3 (en) 2000-06-12
ES2195345T3 (es) 2003-12-01
MEP24908A (en) 2010-10-10
DE69814069T3 (de) 2014-03-27
MEP18008A (en) 2010-10-10
DE69814069T2 (de) 2004-04-01
EG24291A (en) 2009-01-08
CZ297585B6 (cs) 2007-01-10
AR059589A2 (es) 2008-04-16
EE9900550A (et) 2000-06-15
WO1998054171A1 (fr) 1998-12-03
TR199902934T2 (xx) 2000-04-21
US6677455B2 (en) 2004-01-13
ME00198B (me) 2011-02-10
RS50067B (sr) 2009-01-22
LU91871I2 (fr) 2011-11-21
KR20010013126A (ko) 2001-02-26
PL337180A1 (en) 2000-08-14
EP0984957B1 (fr) 2003-05-02
ZA984179B (en) 1998-11-30
TNSN98074A1 (fr) 2005-03-15
NO317518B1 (no) 2004-11-08
RS50005B (sr) 2008-09-29
AR012717A1 (es) 2000-11-08
CA2290963A1 (fr) 1998-12-03
SI1273581T1 (fr) 2005-08-31
SK285137B6 (sk) 2006-07-07
AU7793598A (en) 1998-12-30
UA60334C2 (uk) 2003-10-15
HRP980263A2 (en) 1999-02-28
MY120745A (en) 2005-11-30
NZ500991A (en) 2001-05-25
RS20070459A (sr) 2008-06-05
CN1161351C (zh) 2004-08-11
PT1273581E (pt) 2005-06-30
IS5272A (is) 1999-11-25
DE122012000017I1 (de) 2012-08-16
JP2007161734A (ja) 2007-06-28
MY127793A (en) 2006-12-29
US20080255363A1 (en) 2008-10-16
US6369085B1 (en) 2002-04-09
SE510650C2 (sv) 1999-06-14
ATE239011T1 (de) 2003-05-15
CA2521391C (fr) 2009-09-29
EE03875B1 (et) 2002-10-15
DK1273581T3 (da) 2005-06-06
ID29306A (id) 2001-08-16
US7745466B2 (en) 2010-06-29
CN1258295A (zh) 2000-06-28
NO2012011I1 (no) 2012-06-18
PT984957E (pt) 2003-07-31
KR100527804B1 (ko) 2005-11-15
IL132947A0 (en) 2001-03-19
HK1025962A1 (en) 2000-12-01
US20120252847A1 (en) 2012-10-04
HUP0001849A2 (hu) 2002-05-29
DE69814069D1 (de) 2003-06-05
HU0001849D0 (fr) 2002-05-29
HK1051681A1 (en) 2003-08-15
SI0984957T1 (en) 2003-10-31
DZ2495A1 (fr) 2003-01-25
IS2142B (is) 2006-09-15
JP4002303B2 (ja) 2007-10-31
LU92017I2 (fr) 2012-08-06
EP0984957B3 (fr) 2013-09-18
CA2521391A1 (fr) 1998-12-03
DE69829511T2 (de) 2006-02-16
IS8368A (is) 2006-03-22
US20050075369A1 (en) 2005-04-07
IS2774B (is) 2012-03-15
RU2184115C2 (ru) 2002-06-27
PL193546B1 (pl) 2007-02-28
ATE291574T1 (de) 2005-04-15
US20020198239A1 (en) 2002-12-26
US7411070B2 (en) 2008-08-12
SE9702065D0 (sv) 1997-05-30
EP0984957A1 (fr) 2000-03-15
NO995852D0 (no) 1999-11-29
CA2290963C (fr) 2006-03-28
US20110130570A1 (en) 2011-06-02
NO995852L (no) 2000-01-31
EP1273581B1 (fr) 2005-03-23
HU225987B1 (en) 2008-02-28
ES2195345T7 (es) 2014-01-15
AU722839B2 (en) 2000-08-10
US8076361B2 (en) 2011-12-13
JP2002501529A (ja) 2002-01-15
SE9702065L (sv) 1998-12-01
YU60999A (sh) 2002-03-18
DE69829511D1 (de) 2005-04-28
SA05260296B1 (ar) 2008-04-16
WO1998054171A8 (fr) 1999-12-23
CY2012029I2 (el) 2015-08-05
BR9809509A (pt) 2000-06-20
ES2236407T3 (es) 2005-07-16
HRP980263B1 (en) 2002-02-28
EP1273581A1 (fr) 2003-01-08
MA26500A1 (fr) 2004-12-20
KR100540720B1 (ko) 2006-01-12
TW538040B (en) 2003-06-21
HUP0001849A3 (en) 2003-02-28
NO2011010I1 (no) 2011-06-20

Similar Documents

Publication Publication Date Title
DK0984957T3 (da) Hidtil ukendt form af S-omeprazol
DK0946547T3 (da) Hidtil ukendt forbindelsesform
DK1022334T3 (da) Hidtil ukendte amylaser
DK1077943T3 (da) Heterocykliske inhibitorer af p38
DE69928195D1 (de) Komplettierung von Untrerdruck-Bohrlöchern
ID27092A (id) Pembuatan ftalat anhidrida
EP1110149A4 (fr) Architecture a objet de type cooperatif
NO20002653D0 (no) Sementeringshjelpemidler
ID24247A (id) Penjajaran cetakan tunggal
ID24458A (id) Modifikasi rheologi in-sito poliolefin
DK1000079T3 (da) Hidtil ukendt formulering
EE04154B1 (et) Omeprasooli valmistamise meetod
DE69801283D1 (de) Optisches Halbleiterbauelement
DK1155050T3 (da) Fremstilling af polyolefin
ID28032A (id) TRISIKLIK PIPERIDIN-Δ3-SEBAGAI ANTAGONIS-α2
IS5426A (is) Fjölbrigðaform af dófetilíði
DE60007360T2 (de) Amorphe modifikation von torasemid
DK1088010T3 (da) Fremstilling af polyolefiner
DK0927163T3 (da) Fremstilling af 1-butyl-4-piperidinylmethylamin
FR2782979B1 (fr) Deriveur pliable
DE60021925D1 (de) Flash-spinnen von polycyclopenten
DK1227795T3 (da) Lipidkompleks af alkycycliner
ATA88199A (de) Schalbauteil
UA2651S (uk) Комплект спеціального одягу
DK0923293T3 (da) Behandling af diarré